Career Paths in TB Research: Technical and Academic Paths

By Mbali Nondumiso Mkhonza | May 31, 2023

The Working Group on New TB Vaccines (WGNV) Early Career Researcher Network (ECR Network) recently held the first two virtual discussion sessions in a series on career paths in TB research. Technical/Non-Academic Path On the 15th of February, Dr. Mike Leipold, a Research and Development Scientist at Stanford University, tackled the often-pondered question of “if…

Read More

TB Vaccine Modeling: A discussion with Dr. Richard White

By Ye Eun Grace Jung, MD, MPH | May 30, 2023

Vaccine production, from the product concept to development to licensure to deployment is inherently costly and risky for manufacturers, particularly for vaccines against diseases where the burden lies predominantly in lower- and middle-income countries (LMICs). Thus, vaccine manufacturers frequently prioritize high-income markets that offer higher immediate return on investment. The World Health Organization has been…

Read More

New TB vaccines needed to tackle AMR

By TB Vax ARM | March 6, 2023

New TB vaccines needed to tackle AMR shares a collective call to decision-makers to prioritize TB vaccine R&D as a signature piece of global health and antimicrobial resistance (AMR) agendas. The brief, from the TB Vax ARM, draws on the latest research in health and economic modelling to demonstrate how new TB vaccines could significantly help control drug-resistant TB, in a cost-effective and affordable way.

Read More

Meet the 2023 TB Vaccine Advocacy Fellows

By Shaun Palmer | February 10, 2023

The WGNV and TB Vax ARM, in collaboration with IAVI, are proud to welcome seven participants for a TB vaccine advocacy fellowship. The fellows, representing affected community members, advocates, and early career researchers from five different countries, have come together for a skill-sharing and co-creation program featuring a lineup of workshops led by advocacy experts from around the world. Over the course of the fellowship, the budding TB vaccine advocates will also join forces to develop a collaborative advocacy campaign that will be launched ahead of World TB Day on 24 March.

Read More